This outward-looking proposal brings together stakeholders from multiple sectors in Australia and the UK to create, use and share better understandings of how to measure NCD-relevant green space qualities. These qualities will be tested with robust measures of mental ill-health and cardiometabolic diseases in Sydney, Wollongong, Glasgow and Edinburgh. This new evidence will be used in the co-design of green space quality policy options intended to promote healthier communities for all.
European Platform To Promote Wellbeing And Health In The Workplace (EMPOWER)
Funder
National Health and Medical Research Council
Funding Amount
$499,222.00
Summary
Productivity loss related to mental illness. Digital technologies improve mental health and wellbeing at the workplace. A multimodal digital platform is the software of a website allowing for the interaction of its users and including different modules such as apps, chatbots and virtual assistants. This will be the first multimodal platform developed in Europe. We will provide a critical knowledge transfer for its design, pilot and implementation and will coordinate the impact analysis.
DigiCare4You - An Intersectoral Innovative Solution Involving DIGItal Tools, Empowering Families And Integrating Community CARE Services For The Prevention And Management Of Type 2 Diabetes And Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$489,307.00
Summary
The overall aim of the research is to design and implement an innovative intervention that will bring together the available community-care infrastructure, human resources and services, as well as technological advancements on digital health, for the early prevention and treatment of type 2 diabetes and hypertension. The active involvement of Australian researchers in this international collaboration ensures that this innovation and its benefits will be transferred to Australia in the future.
IMPlementaion ACTion To Prevent DIABETES From Bump 2 Baby (IMPACT DIABETES B2B)
Funder
National Health and Medical Research Council
Funding Amount
$497,609.00
Summary
The IMPACT BUMP 2 BABY (DB2B) multicentre international European Union co-funded program aims to improve healthy lifestyle to prevent gestational diabetes and type 2 diabetes in high risk women and improve the health of their babies over the first 1000 days. Australia is one of four countries that will lead and undertake this work to co-design, implement and evaluate a novel, low cost ,supportive lifestyle intervention for the 30% of women at risk of these conditions in pregnancy and beyond.
COmBining Memantine And Cholinesterase Inhibitors In Lewy Body Dementia Treatment Trial (COBALT)
Funder
National Health and Medical Research Council
Funding Amount
$1,218,120.00
Summary
Many people who have been diagnosed with dementia with Lewy bodies or Parkinson’s disease dementia will be prescribed drugs known as acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine) to help with their symptoms. This research trial, known as COBALT, is designed to find out whether there is any benefit from taking the drug memantine as well. Australian and UK researchers are collaborating on this trial which will recruit eligible participants from both countries.
GloBal RetinAl Imaging CoNSorTium FOR AzheiMer's Disease (BRAINSTORM)
Funder
National Health and Medical Research Council
Funding Amount
$393,099.00
Summary
The retina of the eye displays features of Alzheimer's disease (AD). We have developed a new way to take photos of the eye with a rainbow-coloured flash to detect signs of AD. We now want to test how this and other eye imaging methods compare with brain scans and spinal fluid tests to identify people who are at risk of AD. We will use clinical studies, artificial intelligence, mouse models of AD and donated human tissues to achieve our aims. Our goal is to improve AD detection and care.
E-DADS: Early Detection Of Alzheimer’s Disease Subtypes
Funder
National Health and Medical Research Council
Funding Amount
$488,725.00
Summary
Alzheimer's disease manifests differently in different people. Some people may get the disease at younger ages or they may progress in the disease much faster than others. This grant aims to use large amounts of data from around the world to understand why these differences exist. This knowledge will be converted into a tool where data from a specific individual can be used to forecast if and when they will get the disease and how fast that disease will progress and how it could be prevented.